Sicor Inc.
The Irvine pharmaceutical company reported first-quarter earnings of $7.1 million, or 6 cents a share, compared with a loss of $165,000, or 2 cents a share, for the first quarter last year. Sales rose to $67.5 million from $53.6 million.
The Irvine pharmaceutical company reported first-quarter earnings of $7.1 million, or 6 cents a share, compared with a loss of $165,000, or 2 cents a share, for the first quarter last year. Sales rose to $67.5 million from $53.6 million.
